Inebilizumab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Inebilizumab. Our biosimilar is not afucosylated
Specifications
Detects human CD19
Species Reactivity
Human
Target
CD19
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LRG1, NT (LRG1, LRG, Leucine-rich alpha-2-glycoprotein) (MaxLight 405)
LRG1, NT (LRG1, LRG, Leucine-rich alpha-2-glycoprotein) (MaxLight 405)